Publications by authors named "Steven Douglas"

Claim this Profile
A
A Placebo-Controlled Randomized Trial of the Effects of Escitalopram on Depressive Symptoms and Immune Function in People With HIV.
Dwight L Evans, Sergei Spitsin, Kevin G Lynch, Chelsea D Voytek, Menvekeh G Daramay, Steven D Douglas

Biol Psychiatry Glob Open Sci· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors.
Stephen P H Alexander, Arthur Christopoulos, Anthony P Davenport, Eamonn Kelly, Alistair A Mathie, Steven D Douglas

Br J Pharmacol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein-coupled receptors.
Stephen Ph Alexander, Arthur Christopoulos, Anthony P Davenport, Eamonn Kelly, Alistair Mathie, Steven D Douglas

Br J Pharmacol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV Infection and Depression Among Opiate Users in a US Epicenter of the Opioid Epidemic.
Cecile M Denis, Tiffany Dominique, Peter Smith, Danielle Fiore, Yi-Chien Ku, Steven D Douglas

AIDS Behav· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of aprepitant on kynurenine to tryptophan ratio in cART treated and cART naïve adults living with HIV.
Sergei Spitsin, Vasiliki Pappa, Annemarie Kinder, Dwight L Evans, Jay Rappaport, Steven D Douglas

Medicine (Baltimore)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurokinin-1 receptor signaling induces a pro-inflammatory transcriptomic profile in CD16+ monocytes.
Vasiliki Pappa, Sergei Spitsin, Peter J Gaskill, Steven D Douglas

J Neuroimmunol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic Medication Burden and Complexity for US Patients with Type 2 Diabetes Treated with Glucose-Lowering Agents.
Kristina S Boye, Reema Mody, Maureen J Lage, Steven Douglas, Hiren Patel

Diabetes Ther· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protection against SIV in Rhesus Macaques Using Albumin and CD4-Based Vector-Mediated Gene Transfer.
Sergei Spitsin, Bruce C Schnepp, Mary J Connell, Tehui Liu, Christine M Dang, Steven D Douglas

Mol Ther Methods Clin Dev· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is substance P a nasal epithelial neuropeptide?
Steven D Douglas, Susan E Leeman

J Allergy Clin Immunol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Truncation of neurokinin-1 receptor-Negative regulation of substance P signaling.
Sergei Spitsin, Vasiliki Pappa, Steven D Douglas

J Leukoc Biol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Legacy of CVI.
Marcela F Pasetti, Steven D Douglas, Susan F Plaeger

Clin Vaccine Immunol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Gateway to monocyte entry into the brain: CXCR7, the new orchestra conductor.
Steven D Douglas, Sergei Spitsin

J Leukoc Biol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiinflammatory effects of aprepitant coadministration with cART regimen containing ritonavir in HIV-infected adults.
Sergei Spitsin, Pablo Tebas, Jeffrey S Barrett, Vasiliki Pappa, Deborah Kim, Steven D Douglas

JCI Insight· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Substance P-mediated chemokine production promotes monocyte migration.
Sergei Spitsin, John Meshki, Angela Winters, Florin Tuluc, Tami D Benton, Steven D Douglas

J Leukoc Biol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreased PD-1 Expression on CD8 Lymphocyte Subsets and Increase in CD8 Tscm Cells in Children with HIV Receiving Raltegravir.
Florin Tuluc, Sergei Spitsin, Nancy B Tustin, Jennifer B Murray, Richard Tustin, Steven D Douglas

AIDS Res Hum Retroviruses· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The complement system, neuronal injury, and cognitive function in horizontally-acquired HIV-infected youth.
Jennifer L McGuire, Alexander J Gill, Steven D Douglas, Dennis L Kolson,

J Neurovirol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Substance P and sickle cell disease-a marker for pain and novel therapeutic approaches.
Steven D Douglas

Br J Haematol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Selective Serotonin Reuptake Inhibitor Citalopram Decreases Human Immunodeficiency Virus Receptor and Coreceptor Expression in Immune Cells.
Jeffrey M Greeson, David R Gettes, Sergei Spitsin, Benoit Dubé, Tami D Benton, Steven D Douglas

Biol Psychiatry· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacologic rationale for the NK1R antagonist, aprepitant as adjunctive therapy in HIV.
Jeffrey S Barrett, Sergei Spitsin, Ganesh Moorthy, Kyle Barrett, Kate Baker, Steven D Douglas

J Transl Med· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Central and peripheral markers of neurodegeneration and monocyte activation in HIV-associated neurocognitive disorders.
Jennifer L McGuire, Alexander J Gill, Steven D Douglas, Dennis L Kolson,

J Neurovirol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduction of soluble CD163, substance P, programmed death 1 and inflammatory markers: phase 1B trial of aprepitant in HIV-1-infected adults.
Pablo Tebas, Sergei Spitsin, Jeffrey S Barrett, Florin Tuluc, Okan Elci, Steven D Douglas

AIDS· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling and simulation approach to support dosing and study design requirements for treating HIV-related neuropsychiatric disease with the NK1-R antagonist aprepitant.
Jeffrey S Barrett, Gaurav Bajaj, Jennifer McGuire, Di Wu, Sergei Spitsin, Steven D Douglas

Curr HIV Res· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune markers predictive of neuropsychiatric symptoms in HIV-infected youth.
Jennifer L McGuire, John H Kempen, Russell Localio, Jonas H Ellenberg, Steven D Douglas

Clin Vaccine Immunol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant therapies for HIV-associated neurocognitive disorders.
Jennifer L McGuire, Jeffrey S Barrett, Heather E Vezina, Sergei Spitsin, Steven D Douglas

Ann Clin Transl Neurol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis